Jessamy Tiffen

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Fan Zhang

UNSW Sydney

AUSTRALIA

View details

Michael R. Eccles

University of Otago

NEW ZEALAND

View details

Mark Larance

Senior Lecturer

University of Sydney

AUSTRALIA

View details

Patrick Bertolino

AUSTRALIA

View details

Shudong Wang

University of South Australia

AUSTRALIA

View details

Stuart Cook

Centenary Institute

AUSTRALIA

View details

Kristina Cook

Senior Lecturer and Research Fellow

University of Sydney

AUSTRALIA

View details

Jia Li

Macquarie University

AUSTRALIA

View details

Helen Rizos

Macquarie University

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jessamy Tiffen

Research Interests

Explore related searches

Contact this professor

Articles (12)

BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatment

X and Y Differences in Melanoma Survival Between the Sexes

Correction: Overexpression of VIRMA confers vulnerability to breast cancers via the m<sup>6</sup>A-dependent regulation of unfolded protein response (Cellular and Molecular Life Sciences, (2023), 80, 6, (157), 10.1007/s00018-023-04799-4)

Overexpression of VIRMA confers vulnerability to breast cancers via the m<sup>6</sup>A-dependent regulation of unfolded protein response

Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma

Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7

Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells

A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma

Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers

Sex bias of females in survival from cancer and infections. Is X the answer?

Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma

Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?

Collaborators (9)

Fan Zhang

Michael R. Eccles

Mark Larance

Patrick Bertolino

Shudong Wang

Stuart Cook

Kristina Cook

Jia Li

Helen Rizos

Make your next move.